<DOC>
	<DOCNO>NCT00387803</DOCNO>
	<brief_summary>The purpose study determine cardiac resynchronization therapy combine defibrillation safe effective treatment symptomatic heart failure .</brief_summary>
	<brief_title>Safety Effectiveness Cardiac Resynchronization Therapy With Defibrillation</brief_title>
	<detailed_description>Patients enrol received device cardiac resynchronization therapy ( CRT ) defibrillation . Patients randomize CRT six month evaluate mortality , hospitalization , functional outcome include exercise capacity , quality life , symptomatic status , echocardiographic analysis .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>Symptomatic heart failure Left ventricular ejection fraction &lt; = 35 % QRS width &gt; = 120 m Indicated implantable cardioverter defibrillator Indicated pacemaker Atrial tachyarrhythmias</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>